Drugs & Targets BMS, Nektar form collaboration for CD122-biased agonist February 16, 2018Vol.44 No.07
Drugs & Targets Tivozanib gets NICE nod for first-line treatment of advanced RCC February 16, 2018Vol.44 No.07
Drugs & Targets FDA approves abiraterone acetate in combination with prednisone for high-risk metastatic castration-sensitive prostate cancer February 09, 2018Vol.44 No.06
Drugs & Targets Foundation Medicine and EORTC collaborate comprehensive genomic profiling February 09, 2018Vol.44 No.06
Drugs & Targets Abbott PathVysion HER-2 DNA Probe assay to be used in ANGLE study February 09, 2018Vol.44 No.06
Drugs & Targets FDA approves lutetium Lu 177 dotatate for treatment of GEP-NETS February 02, 2018Vol.44 No.05
Drugs & Targets Amgen receives CHMP positive opinion to add updated survival data to Kyprolis label February 02, 2018Vol.44 No.05
Drugs & Targets Syndax announces immuno-oncology collaboration with AstraZeneca February 02, 2018Vol.44 No.05
Drugs & TargetsFree Foundation Medicine and Pfizer form partnership to develop companion diagnostics January 19, 2018Vol.44 No.03
